4/2
10:34 am
itci
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) had its "neutral" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $132.00 price target on the stock.
Neutral
Report
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) had its "neutral" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $132.00 price target on the stock.
4/1
04:29 pm
itci
Johnson & Johnson Announces Expected Closing Date for Intra-Cellular Acquisition [Yahoo! Finance]
Low
Report
Johnson & Johnson Announces Expected Closing Date for Intra-Cellular Acquisition [Yahoo! Finance]
3/28
02:05 am
itci
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Low
Report
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
3/26
04:38 pm
itci
Jefferies profit misses estimates as bond trading, equity underwriting weaken [Yahoo! Finance]
Low
Report
Jefferies profit misses estimates as bond trading, equity underwriting weaken [Yahoo! Finance]
3/26
04:31 pm
itci
Jefferies profit falls on weaker bond trading, equity underwriting [Yahoo! Finance Canada]
Low
Report
Jefferies profit falls on weaker bond trading, equity underwriting [Yahoo! Finance Canada]
3/25
08:50 am
itci
5 Large Drug Stocks to Watch as Industry Recovers [Yahoo! Finance]
Neutral
Report
5 Large Drug Stocks to Watch as Industry Recovers [Yahoo! Finance]
3/20
02:06 am
itci
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Low
Report
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
3/12
02:11 am
itci
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Low
Report
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
3/4
02:09 am
itci
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Low
Report
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
2/25
12:54 pm
itci
INTRA-CELLULAR THERAPIES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Intra-Cellular Therapies, Inc. - ITCI
Low
Report
INTRA-CELLULAR THERAPIES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Intra-Cellular Therapies, Inc. - ITCI
2/24
11:15 pm
itci
ITCI Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Intra-cellular Therapies, Inc. Is Fair to Shareholders
Low
Report
ITCI Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Intra-cellular Therapies, Inc. Is Fair to Shareholders
2/24
07:16 am
itci
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) was downgraded by analysts at Mizuho from an "outperform" rating to a "neutral" rating. They now have a $132.00 price target on the stock, down previously from $140.00.
Low
Report
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) was downgraded by analysts at Mizuho from an "outperform" rating to a "neutral" rating. They now have a $132.00 price target on the stock, down previously from $140.00.
2/24
02:06 am
itci
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Low
Report
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
2/21
01:36 pm
itci
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.
Neutral
Report
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.
2/21
09:42 am
itci
Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2024 Financial Results [Yahoo! Finance]
Low
Report
Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2024 Financial Results [Yahoo! Finance]
2/21
08:00 am
itci
Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2024 Financial Results
Low
Report
Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2024 Financial Results
2/16
04:03 am
itci
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Low
Report
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
2/8
01:36 am
itci
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Low
Report
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
1/31
07:31 am
itci
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) was downgraded by analysts at Canaccord Genuity Group Inc. from a "buy" rating to a "hold" rating. They now have a $132.00 price target on the stock, up previously from $119.00.
Low
Report
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) was downgraded by analysts at Canaccord Genuity Group Inc. from a "buy" rating to a "hold" rating. They now have a $132.00 price target on the stock, up previously from $119.00.
1/30
02:27 pm
itci
Chronic Pain Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 20+ Companies Working in the Domain [Yahoo! Finance]
Low
Report
Chronic Pain Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 20+ Companies Working in the Domain [Yahoo! Finance]
1/28
11:15 am
itci
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates SSTK and ITCI on Behalf of Shareholders
Low
Report
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates SSTK and ITCI on Behalf of Shareholders
1/23
02:08 am
itci
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Low
Report
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
1/22
12:21 pm
itci
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) had its "sector perform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $132.00 price target on the stock, up previously from $108.00.
Low
Report
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) had its "sector perform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $132.00 price target on the stock, up previously from $108.00.
1/22
07:53 am
itci
J&J Tops Quarterly Profit Estimates on Cancer Drug Sales [BNN Bloomberg (Canada)]
Low
Report
J&J Tops Quarterly Profit Estimates on Cancer Drug Sales [BNN Bloomberg (Canada)]